Patent Assignment
Reel/Frame 043341/0463
Change of Name
Recorded: 2017-07-26
Pages: 4
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2015-12-18
Assignee
IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT, CARLSBAD, CALIFORNIA, 92010
Covered Properties
(10)
Modulation of Apolipoprotein C-Iii Expression
Modulation of Apolipoprotein (a) Expression
Double Stranded Compositions Comprising a 3'-Endo Modified Strand for Use in Gene Modulation
Oligomers Comprising Activated Disulfides Which Bind to Plasma Proteins and Their Use for Delivery to Cells
Chloral-Free Dca in Oligonucleotide Synthesis
Modulation of Apolipoprotein (a) Expression
Synthesis of Sulfurized Oligonucleotides
6-Modified Bicyclic Nucleic Acid Analogs
Supports for Oligomer Synthesis
5'-Modified Bicyclic Nucleic Acid Analogs
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement
Sep 27, 2016
From: FOUNDATION MEDICINE, INC.
To: ROCHE FINANCE LTD
Reel/Frame 040165/0615 →
Release of Security Interest
Jun 30, 2021
From: ROCHE FINANCE LTD
To: FOUNDATION MEDICINE, INC.
Reel/Frame 056715/0711 →
Security Interest
Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →